Skip to the main content

Review article

Hematological abnormalities in rheumatic diseases

Ivo Radman ; Department for Hematology, Clinic for Internal Medicine, Clinical Hospital Centre Zagreb, Zagreb, Croatia


Full text: croatian pdf 453 Kb

page 11-17

downloads: 1.684

cite


Abstract

Haematological abnormalities are present in 25-50% patients with rheumatic diseases. The most common finding is anaemia of chronic disease which is driven by inflammatory cytokines. Hepcidin plays key role in iron homeostasis. It reduces iron absorption from duodenum and iron release from reticuloendothelial cells. Anaemia of chronic disease could be successfully treated by recombinant erythropoietin in combination with iron supplementation. Various abnormalities can be observed in the leukocyte and platelets counts. Other haematological disturbances are considered as part of autoimmune disease. Prolonged antigen stimulation can induce lymphomagenesis and lymphoma incidence in patients with rheumatic diseases is 5 to 6-fold increased compared to normal population.

Keywords

rheumatic diseases; haematological abnormalities; anaemia of chronic disease; leukopenia; thrombocytopenia

Hrčak ID:

125824

URI

https://hrcak.srce.hr/125824

Publication date:

20.10.2006.

Article data in other languages: croatian

Visits: 3.168 *